The abnormal PI3K/AKT activation in cancer cells promotes the expression of ATP-Binding Cassette (ABC) transporters, inhibits apoptosis, and induces tumor growth, thereby contributing to the reduced response to chemotherapeutic medications [137]. This evidence concerns the gene AKT1 and neoplasm.